229 related articles for article (PubMed ID: 20532926)
1. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
[TBL] [Abstract][Full Text] [Related]
2. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
[TBL] [Abstract][Full Text] [Related]
3. [Restriction analysis of genome composition of live influenza vaccine].
Kiseleva IV; Larionova NV; Teley LC; Rudenko LG
Vopr Virusol; 2011; 56(3):28-32. PubMed ID: 21786624
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a live attenuated influenza B virus vaccine candidate.
Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
[TBL] [Abstract][Full Text] [Related]
5. Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.
Isakova-Sivak I; Chen LM; Bourgeois M; Matsuoka Y; Voeten JT; Heldens JG; van den Bosch H; Klimov A; Rudenko L; Cox NJ; Donis RO
Clin Vaccine Immunol; 2014 May; 21(5):722-31. PubMed ID: 24648485
[TBL] [Abstract][Full Text] [Related]
6. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
[TBL] [Abstract][Full Text] [Related]
8. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
[TBL] [Abstract][Full Text] [Related]
9. PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus.
Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Drieszen-van der Cruijsen SK; Basten SM; Heldens JG; van den Bosch H; Rudenko LG
J Gen Virol; 2010 Apr; 91(Pt 4):931-7. PubMed ID: 20007357
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
[TBL] [Abstract][Full Text] [Related]
11. Genetic engineering of live attenuated influenza viruses.
Jin H; Chen Z; Liu J; Kemble G
Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
[TBL] [Abstract][Full Text] [Related]
12. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
Isakova-Sivak I; Korenkov D; Smolonogina T; Tretiak T; Donina S; Rekstin A; Naykhin A; Shcherbik S; Pearce N; Chen LM; Bousse T; Rudenko L
Virology; 2017 Jan; 500():209-217. PubMed ID: 27829176
[TBL] [Abstract][Full Text] [Related]
14. Genotyping and screening of reassortant live-attenuated influenza B vaccine strain.
Lee EY; Lee KH; Jung EJ; Jang YH; Seo SU; Kim HA; Seong BL
J Virol Methods; 2010 May; 165(2):133-8. PubMed ID: 19883691
[TBL] [Abstract][Full Text] [Related]
15. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
[TBL] [Abstract][Full Text] [Related]
16. Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 - Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines.
Krutikova EV; Stepanova EA; Wong PF; Kiseleva IV; Grigor'eva EP; Rudenko LG
Bull Exp Biol Med; 2020 Mar; 168(5):669-672. PubMed ID: 32248454
[TBL] [Abstract][Full Text] [Related]
17. [Leading role of genes coding polymerase complex in attenuation of domestic donor viruses for A and B live influenza vaccine].
Kiseleva IV; Larionova NV; Voeten JT; Teley LC; Drieszen-van der Cruijsen SK; Heldens JG; van den Bosch JF; Rudenko LG
Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):41-7. PubMed ID: 21381376
[TBL] [Abstract][Full Text] [Related]
18. Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
Isakova-Sivak I; de Jonge J; Smolonogina T; Rekstin A; van Amerongen G; van Dijken H; Mouthaan J; Roholl P; Kuznetsova V; Doroshenko E; Tsvetnitsky V; Rudenko L
PLoS One; 2014; 9(7):e102339. PubMed ID: 25058039
[TBL] [Abstract][Full Text] [Related]
19. [Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/Leningrad/134/47/57 (H2N2)-a donor of attenuation of live influenza vaccine].
Medvedeva TE; Kudriavtseva VK; Nevedomskaia GN; Zhikhareva IV; Gushchina MI; Zolotarev FN; Vodeĭko GM; Lisovskaia KV; Iotov VV; Khaĭder MI
Genetika; 1993 Apr; 29(4):681-9. PubMed ID: 8354475
[TBL] [Abstract][Full Text] [Related]
20. [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
Kiseleva IV; Klimov AI; Grigor'eva EP; Larionova NV; Aleksandrova GI; Rudenko LG
Vopr Virusol; 2005; 50(2):14-8. PubMed ID: 15881391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
